Financial Disclosure Policy For Public Commenters Detailed In FDA Guidance
This article was originally published in The Gray Sheet
Executive Summary
Public commenters at FDA open public hearings will not be pressed to disclose financial ties, according to a FDL-1Feb. 15 draft guidance